AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
Top Cited Papers
Open Access
- 29 November 2011
- journal article
- guideline
- Published by Ovid Technologies (Wolters Kluwer Health) in Circulation
- Vol. 124 (22), 2458-2473
- https://doi.org/10.1161/cir.0b013e318235eb4d
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Eplerenone in Patients with Systolic Heart Failure and Mild SymptomsThe New England Journal of Medicine, 2011
- Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trialsThe Lancet, 2010
- Telephone-Delivered Collaborative Care for Treating Post-CABG DepressionJAMA, 2009
- Routine Screening for Depression in Patients With Coronary Heart Disease: Never MindJournal of the American College of Cardiology, 2009
- Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsThe Lancet, 2009
- Efficacy and Safety of Exercise Training in Patients With Chronic Heart FailureJAMA, 2009
- Treadmill Exercise and Resistance Training in Patients With Peripheral Arterial Disease With and Without Intermittent ClaudicationJAMA, 2009
- Cardiovascular Outcomes in Trials of Oral Diabetes MedicationsArchives of Internal Medicine, 2008
- 10-Year Follow-up of Intensive Glucose Control in Type 2 DiabetesThe New England Journal of Medicine, 2008
- Aspirin and Extended-Release Dipyridamole versus Clopidogrel for Recurrent StrokeThe New England Journal of Medicine, 2008